The estimated Net Worth of David Cunningham is at least $60.6 Thousand dollars as of 13 June 2022. Mr. Cunningham owns over 1,000 units of Immucell stock worth over $60,640 and over the last 13 years he sold ICCC stock worth over $0. In addition, he makes $0 as Independent Director at Immucell.
Sign up
Mr. Cunningham ICCC stock SEC Form 4 insiders trading
David has made over 8 trades of the Immucell stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of ICCC stock worth $8,000 on 13 June 2022.
The largest trade he's ever made was exercising 10,000 units of Immucell stock on 19 September 2016 worth over $57,500. On average, David trades about 2,185 units every 248 days since 2011. As of 13 June 2022 he still owns at least 16,000 units of Immucell stock.
You can see the complete history of Mr. Cunningham stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Cunningham biography
David S. Cunningham serves as Independent Director of the Company. Mr. Cunningham is a Chair of the Nominating Committee and of the Compensation and Stock Option Committee of the Board of Directors. He served on the Audit Committee of the Board of Directors until March 31, 2018. Effective January 1, 2018, he became Chief Commercial Officer of Bimeda, Inc., a global animal health company. He was Chief Operating Officer of Axxiom Consulting LLC (which firm has no direct or indirect material interest in the transactions of Axxiom LLC, which firm has been engaged to provide consulting services to the Company) from January 2013 to December 31, 2017. He was President and CEO of Teva Animal Health from May 2009 through December 2012. He was Vice President of Agri Laboratories, Ltd. of St Joseph, Missouri from 2003 to November 2008. Prior to that, he held several management related positions with Boehringer Ingelheim Vetmedica, Inc. and Hoechst-Roussel Agri-Vet from 1990 to 2003.
How old is David Cunningham?
David Cunningham is 54, he's been the Independent Director of Immucell since 2011. There are 9 older and 1 younger executives at Immucell. The oldest executive at Immucell Corp. is Jonathan Rothschild, 66, who is the Independent Director.
What's David Cunningham's mailing address?
David's mailing address filed with the SEC is C/O IMMUCELL CORPORATION,, 56 EVERGREEN DRIVE, PORTLAND,, ME, 04103.
Insiders trading at Immucell
Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin, and Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.
What does Immucell do?
immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.
What does Immucell's logo look like?
Complete history of Mr. Cunningham stock trades at Immucell
Immucell executives and stock owners
Immucell executives and other stock owners filed with the SEC include:
-
Michael F. Brigham,
Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director -
Michael Brigham,
President, Chief Executive Officer, Treasurer, Secretary, Director -
Bobbi Brockmann,
Vice President - Sales and Marketing, Director -
Elizabeth Williams,
Vice President - Manufacturing Operations -
Elizabeth L. Williams,
VP of Manufacturing Operations -
Dr. Joseph H. Crabb Ph.D.,
VP & Chief Scientific Officer -
Joseph Crabb,
Chief Scientific Officer, Vice President -
David Tomsche,
Chairman of the Board -
Paul Wainman,
Independent Director -
Jonathan Rothschild,
Independent Director -
Steven Rosgen,
Independent Director -
David Cunningham,
Independent Director -
John W. Zinckgraf,
Director of Product Devel. -
A. Gustavo Scaffa,
Sr. Director of Quality -
Elizabeth S. Toothaker,
Director of Fin. & Admin. -
Linda Rhodes,
Director -
Brian L. Pessin,
-
Norman H Pessin,
-
Gloria F Basse,
Director -
Anthony B Cashen,
Director -
Robert C Bruce,
Director -
William H Maxwell,
Director -
Bryan K. Gathagan,